Article
Analysis of circulating tumor DNA during checkpoint inhibition in metastatic melanoma using a tumor-agnostic panel.
Melanoma research - 1 Oct 2023
Kisistók Judit, Christensen Ditte Sigaard, Rasmussen Mads Heilskov, Duval Lone, Aggerholm-Pedersen Ninna, Luczak Adam Andrzej, Sorensen Boe Sandahl, Jakobsen Martin Roelsgaard, Oellegaard Trine Heide, Birkbak Nicolai Juul
Abstract excerpt
Immunotherapy has revolutionized treatment of patients diagnosed with metastatic melanoma, where nearly half of patients receive clinical benefit. However, immunotherapy is also associated with immune-related adverse events, which may be severe and persistent. It is therefore important to identify patients that do not benefit from therapy early. Currently, regularly scheduled CT scans are used to investigate size...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.